CanSino Biotechnology is committed to becoming a leader in the industry, manufacturing and providing high quality, innovative vaccine products.

CanSino Biotechnology faithfully and meticulously adheres to applicable government regulations and guidelines regarding Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and Good Laboratory Practices (GLP) during product development, manufacturing and testing and adheres to all applicable regulatory requirements relating to product safety and pharmacovigilance.

The Regulatory Affairs department is responsible for submission and management of all regulatory filings and hosting regulatory agencies. In addition, it is responsible for communication with regulatory agencies, keeping track of new laws and regulations and providing timely communications to the relevant departments.

CanSino establishes and maintains an effective quality system and that is compliant with applicable GMP (Good Manufacturing Practices), Good Laboratory Practices (GLP) and Good Clinical Practices (GCP) regulations and guidelines. The Senior Management has the ultimate responsibility to ensure an effective quality control system is in place. Senior leadership participates in the design, implementation and monitoring of the quality control system and provides strong support.

CanSino is committed to providing leadership, training and the necessary resources to establish quality system and achieve quality excellence. CanSino employees are committed to following quality system procedures and consistently achieving quality excellence through education, training and execution.